DK1502589T3 - Veterinære, vandige injicerbare suspensioner indeholdende florfenicol - Google Patents

Veterinære, vandige injicerbare suspensioner indeholdende florfenicol

Info

Publication number
DK1502589T3
DK1502589T3 DK03017323T DK03017323T DK1502589T3 DK 1502589 T3 DK1502589 T3 DK 1502589T3 DK 03017323 T DK03017323 T DK 03017323T DK 03017323 T DK03017323 T DK 03017323T DK 1502589 T3 DK1502589 T3 DK 1502589T3
Authority
DK
Denmark
Prior art keywords
florfenicol
veterinary
aqueous injectable
injectable suspensions
suspensions containing
Prior art date
Application number
DK03017323T
Other languages
English (en)
Inventor
Erwin Embrechts
Jan Embrechts
Original Assignee
Emdoka Bvba Drug Registration
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emdoka Bvba Drug Registration filed Critical Emdoka Bvba Drug Registration
Application granted granted Critical
Publication of DK1502589T3 publication Critical patent/DK1502589T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
DK03017323T 2003-07-31 2003-07-31 Veterinære, vandige injicerbare suspensioner indeholdende florfenicol DK1502589T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03017323A EP1502589B1 (en) 2003-07-31 2003-07-31 Veterinary aqueous injectable suspensions containing florfenicol

Publications (1)

Publication Number Publication Date
DK1502589T3 true DK1502589T3 (da) 2006-09-25

Family

ID=33522319

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03017323T DK1502589T3 (da) 2003-07-31 2003-07-31 Veterinære, vandige injicerbare suspensioner indeholdende florfenicol

Country Status (13)

Country Link
US (1) US8362087B2 (da)
EP (1) EP1502589B1 (da)
CN (1) CN1829503B (da)
AT (1) ATE327745T1 (da)
AU (1) AU2004262501B2 (da)
CA (1) CA2532755C (da)
DE (1) DE60305687T2 (da)
DK (1) DK1502589T3 (da)
ES (1) ES2266695T3 (da)
PL (1) PL223349B1 (da)
PT (1) PT1502589E (da)
SI (1) SI1502589T1 (da)
WO (1) WO2005013959A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090170954A1 (en) * 2007-12-14 2009-07-02 Schering-Plough Ltd. Process for Recovering Florfenicol and Florfenicol Analogs
US8858970B2 (en) 2011-01-13 2014-10-14 Austin Research Labs Corp. High load dispersions
SG193389A1 (en) 2011-03-10 2013-10-30 Xeris Pharmaceuticals Inc Stable formulations for parenteral injection of peptide drugs
JP6117811B2 (ja) 2011-10-31 2017-04-19 ゼリス ファーマシューティカルズ インコーポレイテッド 糖尿病を処置するための製剤
US9125805B2 (en) * 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
CN102920655A (zh) * 2012-11-26 2013-02-13 哈尔滨市华农威普动物保健品有限公司 氟苯尼考混悬注射液及其制备工艺
US9018162B2 (en) 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
CN103145594B (zh) * 2013-03-26 2014-12-17 四川农业大学 一种制备氟苯尼考微晶体的方法
JP6982495B2 (ja) 2014-08-06 2021-12-17 ゼリス ファーマシューティカルズ インコーポレイテッド ペーストの皮内および/または皮下注射のためのシリンジ、キット、および方法
US9649364B2 (en) 2015-09-25 2017-05-16 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic formulations in aprotic polar solvents
US11590205B2 (en) 2015-09-25 2023-02-28 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
CN117085022A (zh) 2017-06-02 2023-11-21 Xeris药物公司 抗沉淀的小分子药物制剂
AT519742B1 (de) * 2017-09-22 2018-10-15 Rene Weilharter Schusswaffe
CN108904442B (zh) * 2018-08-09 2021-04-06 山西瑞象生物药业有限公司 一种氟苯尼考溶液剂及其制备方法
CN108863864B (zh) * 2018-08-16 2020-07-24 天津大学 一种氟苯尼考-柠檬酸共晶及其制备方法
KR102199186B1 (ko) * 2019-02-13 2021-01-06 주식회사 이글벳 병원성 세균에 의한 질병의 예방 및 치료용 수의학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235892A (en) * 1979-02-05 1980-11-25 Schering Corporation, Patent Dept. 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor
FR2560613B2 (fr) * 1983-05-16 1987-03-27 Pechiney Aluminium Perfectionnement aux barres cathodiques comportant une semelle metallique, pour cuves d'electrolyse hall-heroult
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
US5646151A (en) * 1996-03-08 1997-07-08 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US6074657A (en) * 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation

Also Published As

Publication number Publication date
US8362087B2 (en) 2013-01-29
CN1829503B (zh) 2010-06-23
EP1502589A1 (en) 2005-02-02
CN1829503A (zh) 2006-09-06
PL223349B1 (pl) 2016-10-31
ATE327745T1 (de) 2006-06-15
DE60305687D1 (de) 2006-07-06
PT1502589E (pt) 2006-10-31
CA2532755A1 (en) 2005-02-17
ES2266695T3 (es) 2007-03-01
US20060223889A1 (en) 2006-10-05
SI1502589T1 (sl) 2006-12-31
AU2004262501A1 (en) 2005-02-17
DE60305687T2 (de) 2007-02-22
WO2005013959A1 (en) 2005-02-17
EP1502589B1 (en) 2006-05-31
PL379701A1 (pl) 2006-11-13
AU2004262501B2 (en) 2008-11-20
CA2532755C (en) 2011-10-04

Similar Documents

Publication Publication Date Title
DK1502589T3 (da) Veterinære, vandige injicerbare suspensioner indeholdende florfenicol
ES2244831T5 (es) Uso de pantenol y/o ácido pantoténico y ácido hialurónico y/o hialuronato para la producción de una composición farmacéutica para aplicación oftalmológica
Gad et al. Tolerable levels of nonclinical vehicles and formulations used in studies by multiple routes in multiple species with notes on methods to improve utility
BRPI0406883A (pt) Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
ES2542206T3 (es) Medicamentos que contienen fluoroquinolonas
CA2656825A1 (en) Method of treatment and agents useful for same
TR201907575T4 (tr) Hayvan parazitlerini kontrol etmeye yönelik faydalı ajanlar olarak aminobenzamid türevleri.
BRPI0412527A (pt) composto, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica, e, processo para preparar um composto.
BRPI0507657A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, método para tratar um distúrbio, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo
ATE541554T1 (de) Synergistische konservierungsmischungen
BR0210293A (pt) Uma preparação farmacêutica aquosa de cilostazol para utilização parenteral
BR0213124A (pt) Alimentos para animais incluindo ativos e métodos de uso dos mesmos
EA202193240A1 (ru) Стабилизированные составы, содержащие анти-angptl3 антитела
BRPI0416882A (pt) composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
EP4249069A3 (en) Aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea
EA200970506A1 (ru) Применение индазолметоксиалкановой кислоты для снижения уровней триглицеридов, холестерина и глюкозы
JPS6242924A (ja) 駆虫剤および殺菌剤組成物
BRPI0511563A (pt) uso de bactéria brevibacillus parabrevis, sistema de aqüicultura, aqüiculura e aditivo para a mesma
US20030005889A1 (en) Method of improving hatchability of eggs
KR20140024862A (ko) 히알루론산 또는 히알루론산염을 포함하는 수용액
EA201170164A1 (ru) 9-замещенные-в-карбоксиоксадиазинохинолиновые производные, их получение и их применение в качестве антибактериальных средств
DE602006016168D1 (de) 1,3,5-triazepin-dionen zur Behandlung von Malaria
DK1100463T3 (da) Injicerbare formuleringer indeholdende ramoplanin
TH104391A (th) การป้องกันการติดเชื้อปรสิตภายในตามแนวดิ่ง
TH62584A (th) สารละลายเมลอกซิแคมที่เสถียรชนิดเข้มข้นสูงสำหรับการฉีดแบบไม่ใช้เข็ม